Aclaris Therapeutics宣布将在2025年欧洲皮肤病学与性病学学会大会上发表ATI-2138二期临床试验突破性成果

美股速递
Sep 09, 2025

Aclaris Therapeutics宣布,公司将在2025年欧洲皮肤病学与性病学学会大会上发表关于ATI-2138药物2a期临床试验结果的突破性摘要和口头报告。

该公司将通过这次重要的学术会议平台,向全球皮肤病学专家展示其在研药物ATI-2138的最新临床试验数据和研究进展。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10